Literature DB >> 1339457

Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes.

T Murakami1, T Nishiyama, T Shirotani, Y Shinohara, M Kan, K Ishii, F Kanai, S Nakazuru, Y Ebina.   

Abstract

The type 1 glucose transporter (GLUT1) gene encodes an integral membrane glycoprotein responsible for facilitating transfer of glucose across plasma membrane and is rapidly activated by serum, growth factors, and by oncogenic transformation. To elucidate the molecular mechanisms of regulation of GLUT1 gene expression, we isolated and characterized the mouse GLUT1 gene. DNA elements regulating transcription of the gene were analyzed in transient expression assays after transfection of NIH/3T3 cells with a low background chloramphenicol acetyltransferase (CAT) vector system pSVOOCAT. We identified two enhancer elements; the first one is located 2.7 kilobases upstream of the cap site of the gene which contains the homologous sequences with two 12-O-tetradecanoylphorbol-13-acetate-responsive elements (TREs), a serum response element, a cyclic AMP-responsive element (CRE) and three GC boxes, and the second one is located in the second intron of the gene which contains the homologous sequences with two TREs and one CRE. With the promoter alone the transcription of the gene is activated by src, only slightly activated by ras and is not activated by serum and platelet-derived growth factor. When the gene is accompanied by one of these enhancers, the transcription is activated by all these stimuli.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339457

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

Review 2.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

3.  Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice.

Authors:  Vincent Sarrazy; Manon Viaud; Marit Westerterp; Stoyan Ivanov; Sophie Giorgetti-Peraldi; Rodolphe Guinamard; Emmanuel L Gautier; Edward B Thorp; Darryl C De Vivo; Laurent Yvan-Charvet
Journal:  Circ Res       Date:  2016-02-29       Impact factor: 17.367

4.  HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects.

Authors:  T Tao; Y Tanizawa; A Matsutani; A Matsubara; T Kaneko; K Kaku
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

5.  Gene expression of GLUT3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos.

Authors:  S Nagamatsu; H Sawa; N Inoue; Y Nakamichi; H Takeshima; T Hoshino
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

6.  Functional properties and genomics of glucose transporters.

Authors:  Feng-Qi Zhao; Aileen F Keating
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

Review 7.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

8.  Characterization of the avian GLUT1 glucose transporter: differential regulation of GLUT1 and GLUT3 in chicken embryo fibroblasts.

Authors:  P Wagstaff; H Y Kang; D Mylott; P J Robbins; M K White
Journal:  Mol Biol Cell       Date:  1995-11       Impact factor: 4.138

9.  Peroxisome proliferator-activated receptor gamma agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activity.

Authors:  Nathan T Ihle; Robert Lemos; David Schwartz; Junghwan Oh; Robert J Halter; Peter Wipf; Lynn Kirkpatrick; Garth Powis
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

10.  Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).

Authors:  Stephanie Sieger; Shiming Jiang; Frank Schönsiegel; Helmut Eskerski; Wolfgang Kübler; Annette Altmann; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-23       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.